The all-time high Tenax Therapeutics stock closing price was 11982.01 on March 02, 2000.; The Tenax Therapeutics 52-week high stock price is 3.68, which is 102.2% above the current share price. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Tenax Therapeutics currently has 1 buy rating from Wall Street analysts. Tenax Therapeutics stock was originally listed at a price of $1,168.83 in Dec 31, 1997. The company has a world-class scientific advisory team, including recognized global experts in pulmonary hypertension. The Company's main product is levosimendan. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Log in to see them here or sign up to get started. MORRISVILLE, N.C. (AP) _ Tenax Therapeutics Inc. (TENX) on Monday reported a loss of $23.7 million in its first quarter. Create a list of the investments you want to track. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Tenax Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Tenax Therapeutics's TENX shares and potentially its market environment have been in a bullish cycle in … Overview. Customizable interactive chart for Tenax Therapeutics with latest real-time price quote, charts, latest news, technical analysis and opinions. Morrisville, North Carolina 27560. Have Watchlists? For the best MarketWatch.com experience, please update to a modern browser. Suite 490.
Tenax Therapeutics Inc. ONE Copley Parkway. Log in to see them here or sign up to get started. TENX Stock Rockets on Analyst Coverage While Tenax Therapeutics didn’t issue any news this morning, the company didn’t have to. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. View Tenax Therapeutics, Inc. TENX investment & stock information. When did Tenax Therapeutics' stock split? This browser is no longer supported at MarketWatch. Subscriber Agreement & Terms of Use,
A "buy" rating indicates that analysts believe TENX will outperform the market and that investors should add to their positions of Tenax Therapeutics. By using this site you agree to the
By using this site you agree to the
This browser is no longer supported at MarketWatch. The stock price of Tenax Therapeutics (NASDAQ: TENX) – a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need – increased by over 35% during intraday trading. The Morrisville, North Carolina-based company said it … Intraday Data provided by FACTSET and subject to terms of use. TENX, Tenax Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Visit a quote page and your recently viewed tickers will be displayed here. Comparatively, Exact Sciences has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. A high-level overview of Tenax Therapeutics, Inc. (TENX) stock. Have Watchlists? Tenax Therapeutics Description. Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today... TENX : 2.06 (+2.49%) Tenax Therapeutics, … View real-time stock prices and stock quotes for a full financial overview. Privacy Notice, and
Fiscal Year-end … Historical and current end-of-day data provided by FACTSET. Cookie Notice (). Something went wrong while loading Watchlist. Get Tenax Therapeutics Inc (TENX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The Price And Volume Action In Tenax Therapeutics's Stock Today Tenax Therapeutics (NASDAQ: TENX) is currently up 102.8% to a price of $2.39. The company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding its Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). Something went wrong while loading Watchlist. Company Name: Tenax Therapeutics Inc., Stock Symbol: TENX, Industry: Medical - Drugs, Total Posts: 8113, Last Post: 4/10/2021 11:53:02 PM The latest closing stock price for Tenax Therapeutics as of April 16, 2021 is 1.82.. Tenax Therapeutics (NASDAQ:TENX) was among the trending tickers on Yahoo Finance today, increasing by over 15% to $2.10 USD by 2:30 pm EST. Visit a quote page and your recently viewed tickers will be displayed here. For the best MarketWatch.com experience, please update to a modern browser. Find the latest Institutional Holdings data for Tenax Therapeutics, Inc. Common Stock (TENX) at Nasdaq.com. Historical and current end-of-day data provided by FACTSET. View the latest ratings for TENX. Intraday Data provided by FACTSET and subject to terms of use. Sector Health Care/Life Sciences. Dive deeper with interactive charts and top stories of TENAX THERAPEUTICS, INC.. Stock. Tenax Therapeutics (NASDAQ:TENX) posted its earnings results on Monday. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. TENX | Complete Tenax Therapeutics Inc. stock news by MarketWatch. Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. Get the latest Tenax Therapeutics, Inc. TENX detailed stock quotes, stock … Privacy Notice, and
The acquisition also has Tenax Therapeutics issuing 12.1 million unregistered shares of common stock and securities convertible into common stock to PH Precision Med shareholders. Tenax Therapeutics, Inc. (TENX) Quote Overview ... A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. Since then, TENX stock has increased by 98.1% and is now trading at $2.06. TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket InvestorPlace Jan 19, 2021 GME, LAC, AMC and COHR among premarket gainers Seeking Alpha Jan 19, 2021 The Company is focused on identifying, developing and commercializing products for the critical care market. Copyright © 2021 MarketWatch, Inc. All rights reserved. Investors appear to be responding to the company announcing that. All quotes are in local exchange time. The boost came after an analyst at Ladenburg Thalmann Financial Services said he was “encouraged” by the specialty pharmaceutical company’s update on its study of patients with difficult-to-treat pulmonary hypertension. The company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding its Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). Analyst Ratings. Copyright © 2021 MarketWatch, Inc. All rights reserved. Tenax Therapeutics, Inc. (TENX) Stock Price: $2.09 USD -0.03 (-1.42%) Updated May 7, 2021 11:04 AM EDT - Market open. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. Tenax Therapeutics Inc stock has gained 210.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives TENX stock a score of 69 out of a possible 100.. That rank is influenced by a fundamental score of 88. There are currently no items in this Watchlist.
Intraday data delayed at least 15 minutes or per exchange requirements. Tenax Therapeutics, Inc. is a specialty pharmaceutical company. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. Phone 1 919 855-2100. The company develops levosimendan, which completed a phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction; … TENX: Get the latest Tenax Therapeutics stock price and detailed information including TENX news, historical charts and realtime prices. Tenax Therapeutics, Inc. Common Stock (TENX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Tenax Therapeutics Inc () Stock Market info Recommendations: Buy or sell Tenax Therapeutics stock? With Tenax Therapeutics stock trading at $1.79 per share, the total value of Tenax Therapeutics stock (market capitalization) is $22.59M. Intraday data delayed at least 15 minutes or per exchange requirements. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Historical daily share price chart and data for Tenax Therapeutics since 1997 adjusted for splits. Do you have to pay taxes on withdrawals from 529 college-savings plans? There are currently no items in this Watchlist. Do you have to pay taxes on withdrawals from 529 college-savings plans? Tenax Therapeutics Inc. NASDAQ Updated May 13, 2021 8:51 PM TENX 2.01 0.09 (4.29%). View which stocks have been most impacted by COVID-19. Here’s how to avoid an unpleasant surprise, Israel, Hamas close to cease-fire amid mounting international pressure, CEO of TikTok parent ByteDance to step down, Thai Airways creditors approve reorganization plan, Ford unveils electric F-150, making big bet that buyers will embrace it, End of an era: Microsoft’s Internet Explorer to be retired next year, ‘Everyone’s feeling this’: People are using alcohol to cope with pandemic-related stress — here’s how to drink less, The IRS backlog of 2019 tax returns keeps shrinking — but now for the bad news, H.C. Wainwright Keeps a Buy Rating on Tenax Therapeutics (TENX), TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket. The company has a world-class scientific advisory team, including recognized global experts in pulmonary hypertension. All quotes are in local exchange time. Tenax Therapeutics, Inc. Common Stock, also called Tenax Therapeutics, is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Here’s how to avoid an unpleasant surprise, Israel, Hamas close to cease-fire amid mounting international pressure, CEO of TikTok parent ByteDance to step down, Thai Airways creditors approve reorganization plan, Ford unveils electric F-150, making big bet that buyers will embrace it, End of an era: Microsoft’s Internet Explorer to be retired next year, ‘Everyone’s feeling this’: People are using alcohol to cope with pandemic-related stress — here’s how to drink less, The IRS backlog of 2019 tax returns keeps shrinking — but now for the bad news. TENX stock … The stock has a consensus analyst rating of "Buy." Tenax Therapeutics' stock was trading at $1.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Tenax Therapeutics Inc (TENX : NASDAQ) Stock Price & News - Google Finance. View the latest Tenax Therapeutics Inc. (TENX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Tenax Therapeutics has a beta of 2.46, meaning that its stock price is 146% more volatile than the S&P 500. Total Insider Purchases and Sales Reported to the SEC. View the latest TENX stock quote and chart on MSN Money. Cookie Notice (). Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Create a list of the investments you want to track. Subscriber Agreement & Terms of Use,
Post-Market 0.05 (2.49%) Industry Biotechnology. The specialty pharmaceutical company reported ($1.64) earnings … Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. ‒‒:‒‒.
Comment On Dit La Porte En Anglais,
Terrasse En Travertin Beige,
Millionnaire Français Bitcoin,
Location Ski Rando Annecy,
Demon Slayer Mugen Train Dvd Buy,
The Fall Saison 2 Resume,
Kit Terrasse Composite Brico Dépôt,
Changes Slowed 1 Hour,
Séquence Les Accents Cm1,
Entourage Korean Drama Ep 1 Eng Sub,
Joseph Moreno Amina Now,
07 Ghost 10 Vostfr,
Disney Plus Hulu France,
Comment Regarder Adn Sur Tv Samsung,
Pnl Binance C'est Quoi,
,Sitemap